Compare SGA & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SGA | COCH |
|---|---|---|
| Founded | 1986 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Blank Checks |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.6M | 51.3M |
| IPO Year | 1994 | 2021 |
| Metric | SGA | COCH |
|---|---|---|
| Price | $5.92 | $6.70 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $19.67 |
| AVG Volume (30 Days) | 16.1K | ★ 33.3K |
| Earning Date | 11-12-2026 | 11-05-2026 |
| Dividend Yield | ★ 15.15% | N/A |
| EPS Growth | N/A | ★ 17.45 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $124,829,000.00 | $241,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $15.33 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 5.65 | ★ 7.11 |
| 52 Week Low | $6.55 | $4.72 |
| 52 Week High | $12.76 | $47.70 |
| Indicator | SGA | COCH |
|---|---|---|
| Relative Strength Index (RSI) | 19.91 | 19.07 |
| Support Level | N/A | $4.72 |
| Resistance Level | $9.41 | $7.46 |
| Average True Range (ATR) | 0.44 | 0.41 |
| MACD | -0.11 | 0.93 |
| Stochastic Oscillator | 25.87 | 20.83 |
Saga Communications Inc is a broadcast company engaged in acquiring, developing, and operating broadcast properties. The company's objective is to operate top billing radio stations in mid-sized markets. It derives a majority of its revenue from the sale of advertising for broadcast on its stations.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.